Sofinnova BioEquities, LP — Form D/A

Sofinnova BioEquities, LP of MENLO PARK, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-05-09. $357.9M was reported sold. Industry: Pooled Investment Fund.

Offering

Filed: 2023-05-09
Form: D/A
Accession: 0000919574-23-002895
Industry: Pooled Investment Fund
Exemptions: 06b, 3C, 3C.7
Amount sold: $357.9M
Investors: 65
Date of first sale: 2017-01-03
Security types: equity, fund interests
SEC file number: 021-286773

Issuer

Name: Sofinnova BioEquities, LP
CIK: 0001706472
Entity type: Limited Partnership
Jurisdiction: DELAWARE
Incorporated: 2016
Address: 3000 SAND HILL ROAD BUILDING 3, SUITE 150, MENLO PARK, CA, 94025
Phone: 650-681-8482

Officers, directors & promoters (8)

Name	Role	Location
-- Sofinnova BioEquities GP LLC	Executive Officer	Menlo Park, CA
-- Sofinnova BioEquities GP LLC	Promoter	Menlo Park, CA
-- -- Sofinnova Investments, Inc.	Executive Officer	Menlo Park, CA
-- -- Sofinnova Investments, Inc.	Promoter	Menlo Park, CA
-- -- Sofinnova BioEquities GP LLC	Executive Officer	Menlo Park, CA
-- -- Sofinnova BioEquities GP LLC	Promoter	Menlo Park, CA
-- Sofinnova Ventures, Inc.	Executive Officer	Menlo Park, CA
-- Sofinnova Ventures, Inc.	Promoter	Menlo Park, CA

Other filings by this issuer (9)

Filed	Form	Offering	Sold
2026-05-08	D/A	—	$376.9M
2025-05-09	D/A	—	$363.7M
2024-05-09	D/A	—	$360.5M
2022-05-09	D/A	—	$330.9M
2021-05-14	D/A	—	$333.1M
2020-05-15	D/A	—	$148.3M
2019-05-15	D/A	—	$82.5M
2018-05-15	D/A	—	$23.8M
2017-05-15	D	—	$10.3M

More